Chargement en cours...
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
Less than a year since the start of the COVID-19 pandemic, ten vaccines against SARS-CoV-2 have been approved for at least limited use, with over sixty others in clinical trials. This swift achievement has generated excitement and arrives at a time of great need, as the number of COVID-19 cases worl...
Enregistré dans:
| Publié dans: | J Hematol Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7910769/ https://ncbi.nlm.nih.gov/pubmed/33640005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-021-01046-w |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|